Goudarzi Yasaman, Monirvaghefi Khaterehsadat, Aghaei Salar, Amiri Seyed Siamak, Rezaei Mahdi, Dehghanitafti Atefeh, Azarpey Ali, Azani Alireza, Pakmehr SeyedAbbas, Eftekhari Hamid Reza, Tahmasebi Safa, Zohourian Shahzadi Shahriar, Rajabivahid Mansour
Department of Medical Science, Shahroud Branch, Islamic Azad University, Iran.
Department of Adult Hematology & Oncology, School of Medicine, Ayatollah Khansari Hospital, Arak University of Medical Sciences, Arak, Iran.
Heliyon. 2024 Jul 9;10(15):e34375. doi: 10.1016/j.heliyon.2024.e34375. eCollection 2024 Aug 15.
Hereditary colorectal cancer syndromes, such as Lynch syndrome and familial adenomatous polyposis (FAP), present significant clinical challenges due to the heightened cancer risks associated with these genetic conditions. This review explores genetic profiling impact on surgical decisions for hereditary colorectal cancer (HCRC), assessing options, timing, and outcomes. Genotypes of different HCRCs are discussed, revealing a connection between genetic profiles, disease severity, and outcomes. For Lynch syndrome, mutations in the genes guide the choice of surgery. Subtotal colectomy is recommended for patients with mutations in MLH1 and MSH2, while segmental colectomy is preferred for those with and mutations. In cases of metachronous colon cancer after segmental colectomy, subtotal colectomy with ileorectal anastomosis is advised for all mutations. Surgical strategies for primary rectal cancer include anterior resection or abdominoperineal resection (APR), irrespective of the specific mutation. For rectal cancer occurring after a previous segmental colectomy, proctocolectomy with ileal pouch-anal anastomosis (IPAA) or APR with a permanent ileostomy is recommended. In FAP, surgical decisions are based on genotype-phenotype correlations. The risk of desmoid tumors post-surgery supports a single-stage approach, particularly for certain gene variants. Juvenile Polyposis Syndrome (JPS) surgical decisions involve genetic testing, polyp characteristics with attention to vascular lesions in mutation carriers. However, genetic profiling does not directly dictate the specific surgical approach for JPS. In conclusion this review highlights the critical role of personalized surgical plans based on genetic profiles to optimize patient outcomes and reduce cancer risk. Further research is needed to refine these strategies and enhance clinical guidelines.
遗传性结直肠癌综合征,如林奇综合征和家族性腺瘤性息肉病(FAP),由于与这些遗传疾病相关的癌症风险增加,带来了重大的临床挑战。本综述探讨了基因谱分析对遗传性结直肠癌(HCRC)手术决策的影响,评估了手术选择、时机和结果。讨论了不同HCRC的基因型,揭示了基因谱、疾病严重程度和结果之间的联系。对于林奇综合征,基因中的突变指导手术选择。对于MLH1和MSH2基因突变的患者,建议行次全结肠切除术,而对于 和 基因突变的患者,节段性结肠切除术更受青睐。在节段性结肠切除术后发生异时性结肠癌的情况下,无论何种突变,均建议行次全结肠切除加回肠直肠吻合术。原发性直肠癌的手术策略包括前切除术或腹会阴联合切除术(APR),与具体突变无关。对于先前节段性结肠切除术后发生的直肠癌,建议行直肠结肠切除加回肠袋肛管吻合术(IPAA)或APR加永久性回肠造口术。在FAP中,手术决策基于基因型-表型相关性。术后发生硬纤维瘤的风险支持采用单阶段手术方法,特别是对于某些 基因变异。幼年息肉病综合征(JPS)的手术决策涉及基因检测、息肉特征,尤其要关注 突变携带者的血管病变。然而,基因谱分析并不直接决定JPS的具体手术方法。总之,本综述强调了基于基因谱制定个性化手术计划对于优化患者预后和降低癌症风险的关键作用。需要进一步研究以完善这些策略并加强临床指南。